Unlock Full Company Report

Access verified contacts, investors & buying signals.

Get Access
Recently Funded|Amount: EUR 420.0K|Industry: Biotechnology Research

VAROLIS Secures $420,000 Seed Round for Global Bee Health Innovation

VAROLIS

VAROLIS Logo
N/A
2-10 employees employees (Est.)
Visit Website
View Full Report

Includes contacts, investors & buying signals

VAROLIS, a company dedicated to protecting honey bee colonies, has raised $420,000 in a recent funding round. This significant investment will propel the development of LIMITEX, their proprietary Lithium salt-based therapeutic designed to combat Varroa mites, a pervasive and destructive threat to global honey bee populations and, consequently, agricultural ecosystems. Varroa mites pose a severe and escalating danger to honey bee colonies worldwide, leading to colony collapse and significant economic and ecological repercussions. VAROLIS was founded specifically to address this critical challenge by developing LIMITEX as an innovative, effective, and accessible treatment. This novel therapeutic approach is vital for safeguarding the essential role honey bees play as pollinators, which is directly linked to global agricultural food supply and the maintenance of ecological diversity and stability. The secured capital provides VAROLIS with crucial resources at a pivotal stage in its development. This successful funding round underscores strong investor confidence in the company's scientific foundation and its potential to deliver an impactful solution to a pressing environmental and agricultural issue. VAROLIS plans to prudently deploy these funds towards critical areas, including continued research and development activities, and advancing through the comprehensive regulatory processes necessary for market approval. A primary strategic objective for VAROLIS is to achieve market approval for LIMITEX from leading regulatory bodies. This includes rigorous evaluation and eventual approval by the European Medicines Agency (EMA) and the US Environmental Protection Agency (EPA). Securing these approvals is a fundamental prerequisite for establishing LIMITEX as a widely recognized, effective, and easy-to-use therapy against Varroosis. The company's forward-looking vision is to ultimately contribute significantly to securing global agricultural food supplies and supporting ecological diversity and stability by protecting the world's most vital pollinators.
October 21, 2025

Buying Signals & Intent

Our AI suggests VAROLIS may be interested in solutions related to:

  • Veterinary Medicine
  • Bee Conservation
  • Pesticide Alternatives
  • Biological Research
  • Apiculture Solutions

Sell these products?

Unlock full report to find contacts.

Get Access Now

Investors

Unlock Investor Data

See who invested in VAROLIS and potentially find related investment contacts.

Unlock Premium Access

Key Decision Makers

Unlock Verified Contacts

Get direct email addresses and phone numbers for key decision makers at VAROLIS.

Unlock Contacts Now